EXPRESSION OF A NOVEL BIOMARKER, EPCA, IN ADENOCARCINOMAS AND PRECANCEROUS LESIONS IN THE PROSTATE

EPCA seems to reflect nuclear matrix alterations that occur in the earlier stage of prostate carcinogenesis. Individuals in whom the prostate is influenced by this field effect may be detected with this new biomarker.